As of Sep 23, 2026: fair value of CGABL $18.64, price $15.67, upside +19.0%, quality 54 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CGABL for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $12.35 – $19.84 · fair‑value band $8.88 – $33.55 · the $15.67 price screens below the $18.64 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow CGABL in your weekly email
Every Wednesday you see whether CGABL is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
CGABL (CGABL) currently trades at $15.67, while our model-based Fair Value estimate is $18.64, implying the stock looks roughly 15.9% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $18.12 per share, and 4 of the 11 models we run sit above the $15.67 price.
Bear case: the Asset-Based group reads lowest at $4.59, and 7 of the 11 models stay below the price. Evidence for this calculation is medium.
Scenario range: $8.88 (bear) to $33.55 (bull), the price of $15.67 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 54/100 (solid quality), in the Financials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
CGABL reported revenue of $4.8B in FY2025 versus $8.8B in FY2021, a compound −14.1%/yr. Reported net income was $809M in FY2025, compounding −28.2%/yr from FY2021.
Key figures
Market cap $16.1B · Net margin 16.9% · Return on equity 68.7% · Return on assets (EBIT) 11.8% · Free cash flow $989M · Net cash $2.0B.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (medium confidence).
What moves the price
The share trades about 12% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financials peers we cover trades at −23% fair-value upside, at 19%, CGABL screens cheaper than that median.
Fair Value models
Bear $8.88Fair Value $18.64Bull $33.55
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.81/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−11.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+2.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.3%
Start year 2020 (pandemic). Over 10 years: +4.7% a year
Revenue growth 17 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+37.0%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: adjusted.
−22.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year−22.7%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−25% vs −11%, slowing
Profit margin 2019 to 2024 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.37% → 25%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−0.7%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −3.0% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 659 stocks
Beats the industry median on 3/11 measures
Overall it trails its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside+19% · Above median
Profitability
Return on equity (TTM)69% · Top 25%
Return on assets0% · Below median
Net margin (TTM)17% · Below median
Operating margin (TTM)0% · Bottom 25%
Growth and dividend
Revenue growth0% · Below median
Dividend yield (TTM)3.1% · Below median
Balance sheet
Debt / equity1.16× · Highest 25%
Valuation Multiplesvs Asset Management median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "CGABL Fair Value". https://www.fairvalue-calculator.com/stock/CGABL
Frequently asked questions
Is CGABL overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $18.64 versus a price of $15.67, about +19% upside (undervalued).
What is the fair value of CGABL?
Our model-based fair value for CGABL is $18.64 (as of Sep 24, 2026), built from audited fundamentals. The current price: $15.67.
What is the quality score of CGABL?
CGABL has a Quality Score of 54/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CGABL?
Our model-based price target is the fair value of $18.64 (as of Sep 24, 2026) from 11 valuation models. Cautious scenario $8.88, optimistic scenario $33.55. It is a calculation from audited fundamentals, not an analyst target.
What is the CGABL stock forecast for 2026?
Our models put fair value at $18.64, about +19% upside versus a price of $15.67 (undervalued). Cautious scenario $8.88, optimistic scenario $33.55. The calculation is refreshed regularly with new filings.
What growth is priced into CGABL?
For today's price to be fair in a discounted-cash-flow model, CGABL would have to grow free cash flow by -0.7 % per year for five years (discount rate 9.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +10.3 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of CGABL use?
Our models discount CGABL at 9.2 %: a base by market capitalisation (large), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For CGABL that is -0.7 % per year a year over ten years, using the same discount rate (9.2 %) and the same formula as our fair value.
How much growth has CGABL delivered so far?
Over the past 5 years revenue at CGABL grew +10.3 % a year. The price currently implies -0.7 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of CGABL growing?
The median revenue growth in the sector is +8.3 % a year. That is the yardstick for the growth priced into CGABL (-0.7 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of CGABL?
The free-cash-flow yield on the price is 17.02 %: that much free cash flow CGABL produces per unit of market value. When it exceeds the discount rate of our models (9.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of CGABL?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CGABL it is $18.64 per share (as of Sep 24, 2026), against a price of $15.67. It is the blended result of 11 valuation models (cash flow, earnings, asset, dividend).
Is CGABL stock overvalued or undervalued in 2026?
As of Sep 24, 2026, CGABL trades below its calculated fair value: price $15.67, fair value $18.64, a gap of about +19% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CGABL?
No. The price is what the market pays today ($15.67); the fair value is what the company's own numbers justify ($18.64). For CGABL the two are $2.97 per share apart. That gap is exactly why we show both numbers side by side.
How much is CGABL worth?
The market values CGABL at about $16.1B (market capitalisation, as of Sep 24, 2026). Per share that is $15.67; our models calculate a fair value of $18.64 per share.
What do the bullish and bearish scenarios say about CGABL?
Our models span a range for CGABL: cautious scenario $8.88, base $18.64, optimistic $33.55 per share (as of Sep 24, 2026, price $15.67). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of CGABL?
Balance-sheet figures for CGABL (as of Sep 24, 2026): return on equity 68.7%, debt of 1.16 per unit of equity. They feed the Quality Score of 54/100, which measures business quality independently of the share price.
How far is CGABL from its 52-week high?
CGABL trades at $15.67, about 12% below its 52-week high of $17.90 and 1% above the low of $15.55 (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of $18.64 is for.
Which stocks are comparable to CGABL?
From the same area (Financials) we also value Blackstone Inc, Brookfield Corporation, KKR & Co, State Street Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CGABL stock attractive at the current price?
The data as of Sep 24, 2026: price $15.67, calculated fair value $18.64 (+19%), Quality Score 54/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CGABL calculated?
We run CGABL through 11 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $18.64, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. CGABL currently trades 19 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CGABL?
The closing price on Sep 23, 2026 was $15.67. Our model-based fair value is $18.64, about +19% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CGABL right now?
The model range is unusually wide ($8.88 to $33.55). The outcome hinges heavily on assumptions, so read the point estimate with caution. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Where does the earnings growth of CGABL come from?
Earnings per share at CGABL grew −7.4 % a year from 2013 to 2024. Broken into its drivers: revenue per share −5.9 %, EBIT margin −0.9 %, tax rate −1.6 %, residual (interest, one-offs) +1.0 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of CGABL
How large is the market capitalisation of CGABL?
The market capitalisation of CGABL is $16.1B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the net margin of CGABL?
The net margin of CGABL is 16.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CGABL?
The return on equity (ROE) of CGABL is 68.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CGABL?
On an EBIT basis the return on assets of CGABL is 11.8% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much net cash does CGABL hold?
CGABL holds more cash than debt, $2.0B net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch CGABL in the live analysis
One click puts CGABL on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Some data
Sep 24, 2026